Total Payments
$43,512
2024 Payments
$11,224
Companies
25
Transactions
139
Medicare Patients
1,477
Medicare Billing
$465,393
Payment Breakdown by Category
Consulting$31,510 (72.4%)
Food & Beverage$9,495 (21.8%)
Other$1,275 (2.9%)
Travel$1,232 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,510 | 9 | 72.4% |
| Food and Beverage | $9,495 | 126 | 21.8% |
| Honoraria | $1,275 | 1 | 2.9% |
| Travel and Lodging | $1,232 | 3 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TOPCON MEDICAL SYSTEMS, INC. | $25,413 | 8 | $0 (2023) |
| Alimera Sciences, Inc. | $4,503 | 19 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $4,274 | 5 | $0 (2024) |
| Topcon Healthcare, Inc. | $3,402 | 3 | $0 (2024) |
| Alcon Laboratories Inc | $1,312 | 15 | $0 (2018) |
| Apellis Pharmaceuticals, Inc. | $1,190 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $805.50 | 18 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $343.82 | 7 | $0 (2019) |
| Astellas Pharma US Inc | $267.16 | 7 | $0 (2024) |
| Coherus Biosciences Inc. | $240.47 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,224 | 37 | Regeneron Pharmaceuticals, Inc. ($4,031) |
| 2023 | $27,643 | 41 | TOPCON MEDICAL SYSTEMS, INC. ($25,413) |
| 2022 | $1,451 | 16 | Apellis Pharmaceuticals, Inc. ($697.31) |
| 2021 | $580.01 | 6 | Regeneron Healthcare Solutions, Inc. ($240.15) |
| 2019 | $321.00 | 7 | Regeneron Pharmaceuticals, Inc. ($124.98) |
| 2018 | $1,537 | 23 | Alcon Laboratories Inc ($768.30) |
| 2017 | $756.88 | 9 | Alcon Laboratories Inc ($543.31) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Honoraria | Cash or cash equivalent | $1,275.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 12/13/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Ophthalmology | ||||||
| 10/15/2024 | Topcon Healthcare, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 10/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Ophthalmology | ||||||
| 08/28/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/26/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/20/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $64.40 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/13/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Ophthalmology | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Ophthalmology | ||||||
| 08/02/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Ophthalmology | ||||||
| 07/08/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/17/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/29/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $860.00 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/20/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $98.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 05/16/2024 | Topcon Healthcare, Inc. | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 05/13/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,054 | 2,577 | $876,225 | $406,848 |
| 2022 | 9 | 323 | 435 | $117,191 | $54,661 |
| 2021 | 3 | 60 | 60 | $3,631 | $2,255 |
| 2020 | 2 | 40 | 41 | $2,715 | $1,628 |
Total Patients
1,477
Total Services
3,113
Medicare Billing
$465,393
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 56 | 422 | $527,500 | $279,891 | 53.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 135 | 493 | $124,980 | $43,462 | 34.8% |
| J3590 | Unclassified biologics | Office | 2023 | 85 | 288 | $57,600 | $20,907 | 36.3% |
| 92134 | Imaging of retina | Office | 2023 | 271 | 729 | $54,675 | $20,305 | 37.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 96 | 126 | $22,680 | $11,096 | 48.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 102 | $15,300 | $9,340 | 61.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $17,150 | $7,528 | 43.9% |
| 92250 | Photography of the retina | Office | 2023 | 202 | 278 | $41,700 | $7,386 | 17.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 50 | 50 | $10,750 | $5,152 | 47.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 17 | 19 | $3,890 | $1,781 | 45.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 14 | 44 | $55,000 | $30,129 | 54.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 47 | 71 | $16,150 | $6,467 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $9,310 | $4,686 | 50.3% |
| 92134 | Imaging of retina | Office | 2022 | 97 | 130 | $9,606 | $3,768 | 39.2% |
| J3590 | Unclassified biologics | Office | 2022 | 29 | 52 | $10,400 | $3,700 | 35.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 21 | 21 | $4,515 | $2,230 | 49.4% |
| 92250 | Photography of the retina | Office | 2022 | 55 | 56 | $8,400 | $1,559 | 18.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 11 | 12 | $2,160 | $1,135 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $1,650 | $987.00 | 59.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 29 | $2,117 | $1,489 | 70.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 15 | $570.00 | $425.60 | 74.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 16 | 16 | $944.00 | $340.20 | 36.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 29 | $2,057 | $1,334 | 64.8% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 11 | 12 | $658.00 | $294.48 | 44.8% |
About Dr. Edward Korot, M.D
Dr. Edward Korot, M.D is a Ophthalmology healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2015. The National Provider Identifier (NPI) number assigned to this provider is 1669853768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Korot, M.D has received a total of $43,512 in payments from pharmaceutical and medical device companies, with $11,224 received in 2024. These payments were reported across 139 transactions from 25 companies. The most common payment nature is "Consulting Fee" ($31,510).
As a Medicare-enrolled provider, Korot has provided services to 1,477 Medicare beneficiaries, totaling 3,113 services with total Medicare billing of $465,393. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Grand Rapids, MI
- Active Since 06/15/2015
- Last Updated 01/10/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1669853768
Products in Payments
- EYLEA HD (Biological) $4,164
- ILUVIEN (Drug) $2,510
- YUTIQ (Drug) $1,994
- EYLEA (Biological) $915.22
- Syfovre (Drug) $429.92
- AcrySof (Device) $420.24
- Centurion (Device) $389.07
- Cimerli (Biological) $240.47
- OZURDEX (Drug) $234.67
- STELLARIS (Device) $223.31
- ReSTOR (Device) $169.63
- CyPass (Device) $149.70
- EVA, combined machine (Device) $149.47
- LUMERA (Device) $125.11
- ORA (Device) $123.91
- VABYSMO (Drug) $119.53
- Susvimo (Drug) $114.90
- Humira (Biological) $105.44
- ARTEVO 800 (Device) $101.60
- LATANOPROSTENE BUNOD (Drug) $93.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Grand Rapids
Dr. Thomas Aaberg, Md, MD
Ophthalmology — Payments: $329,714
Ophthalmology $329,714
Scott Westhouse, D.o, D.O
Ophthalmology — Payments: $96,762
Ophthalmology $96,762
Roman Krivochenitser, M.d, M.D
Ophthalmology — Payments: $21,287
Ophthalmology $21,287
Dr. Joseph Boss, M.d, M.D
Ophthalmology — Payments: $21,268
Ophthalmology $21,268
Dr. Marcus Muallem, Md, MD
Ophthalmology — Payments: $14,992
Ophthalmology $14,992
Dr. Liliya Sutherland, D.o, D.O
Ophthalmology — Payments: $13,103
Ophthalmology $13,103